<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Management of hypercholesterolemia after heart transplantation in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Management of hypercholesterolemia after heart transplantation in adults</h1>
<div class="graphic"><div class="figure"><div class="ttl">Management of hypercholesterolemia after heart transplantation in adults</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_footnotes"><p>LDL-C: low-density lipoprotein cholesterol; PCSK9: proprotein convertase subtilisin/kexin type 9.</p>
<p>* For most patients after heart transplantation, we prefer initial therapy with pravastatin; rosuvastatin is a reasonable initial therapy or secondary therapy for patients who have an unmet LDL-C goal.</p>
<p>¶ The maximal daily doses of the preferred statins after heart transplantation are pravastatin 40 mg and rosuvastatin 20 mg. Starting doses are pravastatin 20 mg daily and rosuvastatin 10 mg daily. For further information on the management of statin intolerances, refer to UpToDate content on treatment of hyperlipidemia in patients after transplantation.</p>
<p>Δ Diagnoses that may require treatment to a specific LDL-C value include diabetes, peripheral vascular disease, and stroke. For further information on LDL-C management for these and other atherosclerotic risk factors, refer to the relevant UpToDate content.</p>
◊ For patients with heart transplantation, ezetimibe and PCSK9 inhibitors have some evidence of safety. Other therapies for reducing LDL-C may interact with immunosuppressive agents. For further details on interactions between immunosuppression and hyperlipidemia therapies, refer to UpToDate content on cholesterol therapy and organ transplantation and the <a href="https://www.uptodate.com/drug-interactions">Lexicomp drug interactions</a> database included with UpToDate.</div><div id="graphicVersion">Graphic 139419 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
